Federal Health Agencies Call to Pause Johnson & Johnson Vaccine
Summary from the AllSides News Team
Featured Coverage of this Story
From the Left
FDA, CDC call for pause in use of Johnson & Johnson vaccine after six reported cases of rare blood clotsFederal health officials on Tuesday called for a pause in the use of the Johnson & Johnson coronavirus vaccine, saying they are reviewing reports of six U.S. cases of a rare and severe type of blood clot in people after receiving the vaccine.
All six cases occurred among women between the ages of 18 and 48, and symptoms occurred six to 13 days after vaccination, according to a statement issued by the Food and Drug Administration and the Centers for Disease Control and Prevention.
The CDC will hold a meeting...
From the Left
US recommends ‘pause’ for J&J vaccine over clot reportsThe U.S. is recommending a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.
In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said they were investigating unusual clots in six women that occurred 6 to 13 days after vaccination. The clots occurred in veins that drain blood from the brain and occurred together with low platelets. All six cases were in women between the ages of 18 and 48.
The...
From the Right
Federal health agencies call to pause Johnson & Johnson vaccine after clotting casesFederal health agencies requested an abrupt pause in the use of Johnson & Johnson’s single-dose coronavirus vaccine after six U.S. recipients developed a rare disorder involving blood clots within nearly two weeks of vaccination, officials said on Tuesday.
The Food and Drug Administration, along with the Centers for Disease Control and Prevention, announced the news on Twitter and will reportedly stop distributing the vaccine at federal sites and encourage states to do so while an investigation is underway for safety issues.
“Today FDA and @CDCgov issued a statement regarding the...
AllSides Picks
April 23rd, 2024
April 23rd, 2024
April 22nd, 2024